KCAT	Homo sapiens	0.28	t-butyloxycarbonyl-Gly-L-Leu-L-Ala-L-Arg-thiobenzyl ester	*subunit Bb, mutant with Cys-residues at positions 428, 435
KCAT	Homo sapiens	0.65	t-butyloxycarbonyl-Gly-L-Leu-L-Ala-L-Arg-thiobenzyl ester	*subunit Bb, wild-type
KCAT	Homo sapiens	0.0038	complement component C5	*37&Acirc;&deg;C, enzyme ZymC3b,Bb, surface-bound C5 convertase formed on zymosan particles
KCAT	Homo sapiens	0.0071	complement component C5	*37&Acirc;&deg;C, enzyme CVFn,Bb
KCAT	Homo sapiens	0.0082	complement component C5	*surface-bound C3/C5 convertase (EMan,M1,C4b,C2a)
KCAT	Homo sapiens	0.011	complement component C5	*37&Acirc;&deg;C, enzyme C3b,Bb
KCAT	Homo sapiens	0.011	complement component C5	*surface-bound C3/C5 convertase (ZymM1,C4b,C2a)
KCAT	Homo sapiens	0.012	complement component C5	*37&Acirc;&deg;C, enzyme CVFh,Bb
KCAT	Homo sapiens	0.013	complement component C5	*high-affinity C5 convertase (ZymM1,C3bC4b,C2a)
KCAT	Homo sapiens	0.026	complement component C5	*high-affinity C5 convertase (EMan,C3bC4b,C2a)
KCAT	Homo sapiens	0.107	complement component C3	*10&Acirc;&deg;C
KCAT	Homo sapiens	0.107	complement component C3	*
KCAT	Homo sapiens	0.202	complement component C3	*20&Acirc;&deg;C
KCAT	Homo sapiens	0.202	complement component C3	*
KCAT	Homo sapiens	0.367	complement component C3	*30&Acirc;&deg;C
KCAT	Homo sapiens	0.367	complement component C3	*
KCAT	Homo sapiens	0.472	complement component C3	*37&Acirc;&deg;C
KCAT	Homo sapiens	0.472	complement component C3	*
KCAT	Homo sapiens	1.78	complement component C3	*37&Acirc;&deg;C
KM	Homo sapiens	0.0000075	complement component C5	*high-affinity C5 convertase (EMan,C3bC4b,C2a)
KM	Homo sapiens	0.0000086	complement component C5	*high-affinity C5 convertase (ZymM1,C3bC4b,C2a)
KM	Homo sapiens	0.000036	complement component C5	*37&deg;C, enzyme CVFn,Bb
KM	Homo sapiens	0.00124	complement component C5	*37&deg;C, enzyme ZymC3b,Bb, surface-bound C5 convertase formed on zymosan particles
KM	Homo sapiens	0.00273	complement component C5	*surface-bound C3/C5 convertase (ZymM1,C4b,C2a)
KM	Homo sapiens	0.00586	complement component C3	*37&deg;C
KM	Homo sapiens	0.0116	complement component C3	*37&deg;C
KM	Homo sapiens	0.0116	complement component C3	*
KM	Homo sapiens	0.014	complement component C5	*37&deg;C, enzyme CVFh,Bb
KM	Homo sapiens	0.0144	complement component C3	*30&deg;C
KM	Homo sapiens	0.0144	complement component C3	*
KM	Homo sapiens	0.0176	complement component C3	*20&deg;C
KM	Homo sapiens	0.0176	complement component C3	*
KM	Homo sapiens	0.024	complement component C5	*37&deg;C, enzyme C3b,Bb
KM	Homo sapiens	0.0264	complement component C3	*10&deg;C
KM	Homo sapiens	0.0264	complement component C3	*
KM	Homo sapiens	0.0688	complement component C5	*surface-bound C3/C5 convertase (EMan,M1,C4b,C2a)
KM	Homo sapiens	2.75	t-butyloxycarbonyl-Gly-L-Leu-L-Ala-L-Arg-thiobenzyl ester	*subunit Bb, mutant with Cys-residues at positions 428, 435
KM	Homo sapiens	5.63	t-butyloxycarbonyl-Gly-L-Leu-L-Ala-L-Arg-thiobenzyl ester	*subunit Bb, wild-type
MW	Tachypleus tridentatus	185000	*	*x * 185000, SDS-PAGE
MW	Homo sapiens	200000	*	*x * 200000, enzyme component C3, SDS-PAGE
SA	Homo sapiens	-999	*	*deposition of the solid-phase activation product complement component C3b on a mannan-coated surface at a high concentration of 17% of human serum determined, function of the proteases MASP-1 and MASP-2 in the generation of complement component C3 convertase at high but not at low serum concentrations
SA	Mus musculus	-999	*	*complement component C3 cleavage through the mannan-binding lectin (MBL) pathway in mouse sera determined, experimental conditions described
SA	Homo sapiens	-999	*	*ability of human properdin to restore LPS-dependent AP complement activity in properdin-deficient mouse serum shown to be correlated with the human properdin-binding affinity of the LPS
SA	Mus musculus	-999	*	*LPS- and LOS-induced AP complement activation abolished in properdin-deficient mouse serum, zymosan- and cobra venom factor-induced AP complement activation observed, classical pathway-triggered AP complement amplification only partially or minimally affected in properdin-deficient mice, ability of human properdin to restore LPS-dependent AP complement activity in properdin-deficient mouse serum shown to be correlated with the human properdin-binding affinity of the LPS
SA	Homo sapiens	-999	*	*hemolysis assay to assess inhibition by DAF mutants described, equilibrium analysis of recombinant soluble DAF mutants binding to complement component C3b shown, kinetic constants for binding of DAF mutants to the complement component C3b and fragment Bb and ability to decay AP convertase determined, interaction of DAF with properdin and decay of properdin-stabilized convertase indicated, binding kinetics of fragment Bb to recombinant soluble DAF mutants DAF1234, DAF23 and DAF34 determined, decay of AP C3 convertase by DAF and DAF mutants monitored
SA	Homo sapiens	-999	*	*central role of the amplification loop in complement activation discussed, development of a model placing the amplification loop at the center of the complement system as a means to expand complement component C3/C5 activation and irrespective of the origin of the triggering complement component C3b molecules
SA	Homo sapiens	-999	*	*convertase formation and activity shown, Western blot, ELISA and fluorescence resonance energy transfer (FRET) used to study formation of the fluid-phase AP convertases C3(H2O)Bb and C3bBb, regulation by factor H and factor I determined, higher affinity for complement component C3(H2O) than for complement component C3b determined, convertase activity of C3bBb higher than of C3(H2O)Bb, C3(H2O)Bb convertase more resistant to inactivation by factor H and factor I than the C3bBb convertase, 25% of initial activity of complement component C3(H2O)Bb retained at conditions that totally inactivate C3bBb
SA	Homo sapiens	-999	*	*plasma levels of complement components determined in patients with severe trauma
